This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Summit on Hematology and Blood Disorders" (Hematology 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at hematology@magnusconference.com or call + 1 (702) 988 2320.
The study of blood, blood-related organs and tissues (e.g., bone marrow, spleen, and liver), and blood illnesses is known as haematology. Inherited genetic mutations, environmental stressors, and nutritional deficiencies can all cause blood problems. Hemophilia (reduced clotting ability), clotting disorders (predisposition to create blood clots), and blood malignancies (i.e., liquid tumours) such as leukemias, lymphomas, and myelomas are all common haematological illnesses. Because the pharmacological targets of blood disorders are mostly found in the blood, transport and distribution problems are less common than with diseases that affect other parts of the body. Because blood has access to all tissues and organs, this property emphasises the importance of target specificity and constant monitoring of unforeseen consequences. The discovery of novel medications for cancer indications has seen the greatest rapid expansion. The development of tailored medicines for particular patient subgroups characterised by genetic abnormalities is one emphasis in blood drug discovery.
Title : Single cell multi-omics in PBMC’s
Peter J Van Der Spek, Erasmus University Medical Center, Netherlands
Title : Myeloid neoplasms and molecular genetic alterations (Germline vs Somatic) that characterize specific entities in pediatric patients
Aida I Richardson, Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Title : Overview of 2021 guidelines on the diagnosis of Von Willebrand Disease (VWD)
Maryam Asif, University of Washington, United States
Title : Clinical management of sickle cell disease
Lambros K Bourantas, Larnaca General Hospital, Cyprus
Title : Clonal evolution in children with inherited bone marrow failure syndromes
Raykina Elena, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Title : Blood transfusion challenges for one stop perioperative clinic care
Hanadi M Aljedani, King Abdullah Medical City, Saudi Arabia